Citeline Podcasts

Mark McClellan, a former FDA commissioner and current director of the Duke-Margolis Center, spoke to MedTech Insight about a new report recommending multi-year demonstration projects for a new coordinating center aimed at launching FDA's National Evaluation System for health Technology.

On this week's podcast, Tina Tan and David Filmore discuss the ophthalmology market, in particular Tina's recent interview with James Mazzo, and the sale of it Abbott Medical Optics to Johnson & Johnson for more than $4bn.

On this week's podcast, Tina Tan and David Filmore discuss the ophthalmology market, in particular Tina's recent interview with James Mazzo, and the sale of it Abbott Medical Optics to Johnson & Johnson for more than $4bn.

On this week's podcast, Tina Tan and David Filmore discuss the ophthalmology market, in particular Tina's recent interview with James Mazzo, and the sale of it Abbott Medical Optics to Johnson & Johnson for more than $4bn.

On this week's podcast, Medtech Insight journalists discuss the latest update on the troubled Abbott-Alere merger, an appeal in an off-label case, the continuing narrative St. Jude's short-seller/cybersecurity controversy and updates from FDA.

On this week's podcast, Medtech Insight journalists discuss the latest update on the troubled Abbott-Alere merger, an appeal in an off-label case, the continuing narrative St. Jude's short-seller/cybersecurity controversy and updates from FDA.

On this week's podcast, Medtech Insight journalists discuss the latest update on the troubled Abbott-Alere merger, an appeal in an off-label case, the continuing narrative St. Jude's short-seller/cybersecurity controversy and updates from FDA.

On this week's podcast, David Filmore and Ferdous Al-Faruque discuss the details of the recently inked draft medical device draft user-fee agreement between FDA and industry, including some wins and losses for each side. Also, short-seller allegations that St. Jude Medical's devices are vulnerable to hacking.

On this week's podcast, David Filmore and Ferdous Al-Faruque discuss the details of the recently inked draft medical device draft user-fee agreement between FDA and industry, including some wins and losses for each side. Also, short-seller allegations that St. Jude Medical's devices are vulnerable to hacking.

On this week's podcast, David Filmore and Ferdous Al-Faruque discuss the details of the recently inked draft medical device draft user-fee agreement between FDA and industry, including some wins and losses for each side. Also, short-seller allegations that St. Jude Medical's devices are vulnerable to hacking.